Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

Fig. 4

Heatmap for tumor inflammation signature (TIS) profile considered evaluable for objective response for all cases (A), adenocarcinoma (B), and squamous cell carcinoma (C). Columns represent patients and rows represent genes. The expression levels have been scaled within rows for visualization. The top row shows whether the patient was a responder (magenta) or a non-responder (blue)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us